Workflow
公司债务风险
icon
Search documents
长城电工为子公司提供1亿元担保,股价短期走势偏弱
Jing Ji Guan Cha Wang· 2026-02-14 06:27
近7个交易日(截至2026年2月13日),长城电工股价震荡下行,区间跌幅0.43%,最新收盘价9.37元(2 月13日),单日下跌1.26%。期间成交额约3.62亿元,换手率活跃度一般(2月12日换手率2.18%)。技 术面显示股价处于20日布林线下轨附近(支撑位8.63元),MACD指标呈负值,短期走势偏弱。同期所 属电网设备板块下跌1.71%,公司表现略优于板块但弱于大盘。 以上内容基于公开资料整理,不构成投资建议。 经济观察网 2026年2月12日,长城电工(600192)发布公告,为其全资子公司天水长城开关厂集团有限 公司提供1亿元银行信贷业务担保,旨在满足子公司日常经营资金需求。截至公告日,公司及控股子公 司对外担保总额达5.24亿元,占最近一期经审计净资产的44.37%。该事件可能影响公司债务风险预期, 但担保属于年度计划内操作,未出现逾期情况。 股票近期走势 ...
ST宁科: ST宁科关于重大诉讼的结果公告
Zheng Quan Zhi Xing· 2025-05-22 10:21
Core Viewpoint - Ningxia Zhongke Biotechnology Co., Ltd. is facing significant financial distress, with a total debt of 2.164 billion yuan and overdue debts amounting to 1.81 billion yuan, leading to a serious risk of bankruptcy [1][5]. Group 1: Debt and Financial Status - The company's total debt scale is 2.164 billion yuan, with overdue debts totaling 1.81 billion yuan and litigation-related debts amounting to 1.26 billion yuan [1][5]. - Most of the company's bank accounts, except for those of its subsidiary Ningxia Huahui Environmental Technology Co., Ltd. and its wholly-owned subsidiary Ningxia Tianfu Activated Carbon Co., Ltd., are frozen, severely impacting its liquidity [1][5]. - Although the bank accounts of Zhongke New Materials Co., Ltd. have been unfrozen, the company is currently lacking sufficient funds and liquid assets to repay its debts, indicating a significant risk to its ongoing operations [1][5]. Group 2: Litigation Status - The company is a defendant in multiple lawsuits, including disputes over loan contracts, equity transfer contracts, sales contracts, construction contracts, and securities fraud [2][5]. - A recent court ruling from the Guangdong Zhanjiang Intermediate People's Court dismissed the claims made by Guangdong Nanyue Bank against the company, stating that the bank failed to verify the public disclosure of the guarantee matters [3][5]. - The court supported the company's defense regarding the "maximum pledge contract," ruling that it does not have legal effect, thus not impacting the company's current or future profits [3][5].
ST宁科: ST宁科关于重大诉讼的进展公告
Zheng Quan Zhi Xing· 2025-05-19 10:00
Core Viewpoint - Ningxia Zhongke Biotechnology Co., Ltd. is facing significant financial distress, with a total debt of 2.164 billion yuan and overdue debts amounting to 1.81 billion yuan, leading to severe operational challenges and potential bankruptcy risks [1][5]. Debt and Financial Situation - The company's total debt stands at 2.164 billion yuan, with overdue debts totaling 1.81 billion yuan and litigation-related debts amounting to 1.839 billion yuan [1][5]. - Most of the company's bank accounts, except for those of its subsidiaries, are frozen, severely limiting its liquidity and ability to repay debts [1][5]. - Despite the unfreezing of bank accounts for Zhongke New Materials, the company lacks sufficient funds and liquid assets for debt repayment, indicating a critical risk to its ongoing operations [1][5]. Litigation and Legal Proceedings - The company is currently a defendant in multiple lawsuits, including disputes over loan contracts, equity transfer contracts, sales contracts, construction contracts, and securities fraud [2][5]. - A specific lawsuit regarding a construction contract dispute has resulted in a court ruling, which the company has decided not to appeal [3][5]. - The financial impact of ongoing litigation has been accounted for in the company's audited annual report for 2024, but the exact effects on current and future profits remain uncertain due to the status of various lawsuits [2][3].